Doxazosin Mesylate Capsules Suppliers & Bulk Manufacturers

Available Forms: Extended-release (ER) capsules

Available Strengths: 4 mg, 8 mg, and 12 mg

Reference Brands: Cardura XL

Category: Drugs Using Osmotic Pump Systems

Doxazosin mesylate Capsules is available in Extended-release (ER) capsules and strengths such as 4 mg, 8 mg, and 12 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Doxazosin mesylate Capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Doxazosin mesylate Capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Cardura XL® (doxazosin mesylate) is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity under MDR standards. These formulations undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality doxazosin formulations supporting hypertension and BPH management worldwide, promoting treatment safety and effectiveness.